Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies

The objective of this study was to evaluate the risk of malignancy (ROM) associated with atypia of undetermined significance (AUS) and suspicious follicular neoplasm (SFN) core needle biopsy (CNB) categories after further sub-classification. Data from 2267 thyroid nodules evaluated by ultrasound-guided CNB, from January to December 2015, were retrospectively reviewed. AUS nodules (n = 556) were sub-classified as follows: (1) architectural atypia (AUS-A;n = 369, 66.4%), (2) cytologic atypia (AUS-C;n = 35, 6.3%), (3) cytologic/architectural atypia (AUS-C/A;n = 85, 15.3%), or (4) oncocytic atypia (AUS-O;n = 67, 12.1%). SFN nodules (n = 172) were sub-classified as follows: (1) architectural atypia only (SFN-A;n = 110, 64%), (2) cytologic/architectural atypia (SFN-C/A;n = 24, 14%), or (3) oncocytic atypia (SFN-O;n = 38, 22%). Diagnostic surgery was performed in 162 (30.2%) AUS cases and 105 (61%) SFN cases. The ROM of each sub-category was evaluated. The overall ROM was 15.3–52.5% in AUS nodules and 35.5–58.1% in SFN nodules. The ROM was higher in the AUS-C (22.9–88.9%) and AUS-C/A (32.9–90.3%) g roups than AUS-A (11.9–40%) and AUS-O (7.5–41.7%). In the SFN category, ROM in the SFN-C/A group was also higher than SFN-A or SFN-O (37.5–75%, 40–57.9%, and 21.1–47.1%, respectively). Our study shows that the ROM was higher in AUS or SFN sub-categories with cytologic atypia than those wit hout cytologic atypia. Because of the heteroge...
Source: Endocrine Pathology - Category: Pathology Source Type: research